Here you will find companies that develop or already produce and provide diagnostic tests for the detection of an acute or past infection with SARS-CoV-2.
Results of tests of travel returnees at Frankfurt Airport in summer 2020 by travel countries and by German regions (zip code)/ Airport Statistic
Evaluation of antiviral substances (incl. re-purposing; perhaps participation in an EU consortium); building up diagnostic capacity; support for clinics and relief measures on site
RT-qPCR kit for the detection of SARS CoV-2
Delivery of components for COVID-19 qPCR tests
Metabolic analysis for patient stratification with COVID-19 disease
Development and production of customized monoclonal and polyclonal antibodies against various SARS CoV-2 proteins, suitable for diagnostic and research.
BioSpring manufactures custom oligonucleotides under ISO13485 for the development of COVID-19 diagnostics. Production volumes range from a few milligrams to several hundred grams
DNA / RNA diagnostics, R&D production and sale of diagnostics; also COVID-19 production and marketing
Assay development (diagnostics)
PCR test for SARS-CoV-2
Corona acute diagnosis and corona antibody test
Significant test activities for symptomatic and non-symptomatic population groups
Sale of SARS-CoV-2 diagnostic kits; CoV-2 assays on Unyvero platforms; NGS service and Bio IT for CoV-2 epidemiology
Development of clinical test kits for SARS-CoV-2 and test kits for the detection of SARS-CoV-2 in swab samples of surfaces and in food or feed samples
Clone and process pevelopment: support for the improvement of the Airway AT-100 yield and process support in production (Airway is testing approval AT-100 as a COVID-19 therapeutic agent, Airway AT-100 was developed in the Glycotope cell line); Medium term: IGa platform for SARS virus control (consortium in planning); Clinical Immuno-monitoring:; Immediately possible: detection of COVID19 antibodies and qPCR assays (detection of Corona Virus)
Development of portable rapid test SARS-CoV-2
RT-qPCR systems for the detection of SARS CoV-2, development of an ELISA test for the detection of antibodies, and a serological differentiation test to distinguish between seasonal corona viruses and the current SARS CoV-2
Analysis of antibody responses in patient serum for diagnostic and vaccine development
Peptide synthesis (e.g. antigenic sequences) and generation of peptide-specific antibodies
Production of RIDA®GENE SARS-CoV-2 RUO kit
Diagnostic test SARS-CoV-2
The test performed by Sens-ID for the determination of SARS-CoV-2 antibodies in human blood is a detection for individual immunity testing.
Laboratory diagnostics (qPCR) for the regional test centers / tapping points
Development and delivery of SARS-CoV-2 detection assays and sample preparation; We are working on capable antibody tests and ELISA tests for the detection of immunity to CoV-2 ; We are examining opportunities, further analytical methods, such as mass spectrometry, for the diagnosis of CoV-2.
Antibody development against hCOV-2; Drug candidates for therapy; Antibodies for diagnostics possible